Budesonide Delayed-release Capsules

Budesonide Delayed-release Capsules
SPL v8
SPL
SPL Set ID d645a346-c99b-4de7-9bca-69e73266d6b4
Route
ORAL
Published
Effective Date 2025-02-12
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Budesonide (3 mg)
Inactive Ingredients
Acetyltributyl Citrate Alcohol Ammonia Butyl Alcohol Dimethicone Ethylcelluloses Ferric Oxide Red Ferric Oxide Yellow Ferrosoferric Oxide Gelatin Isopropyl Alcohol Methacrylic Acid And Ethyl Acrylate Copolymer Polysorbate 80 Potassium Hydroxide Propylene Glycol Shellac Sodium Lauryl Sulfate Sucrose Talc Titanium Dioxide Triethyl Citrate Water

Identifiers & Packaging

Pill Appearance
Imprint: 720 Shape: capsule Color: orange Color: white Size: 19 mm Score: 1
Marketing Status
ANDA Active Since 2017-06-08

Description

NDC 70771-1075-1 in bottle of 100 capsules Budesonide Delayed-Release Capsules 3 mg 100 capsules Rx only


Medication Information

Description

NDC 70771-1075-1 in bottle of 100 capsules Budesonide Delayed-Release Capsules 3 mg 100 capsules Rx only

Package Label.principal Display Panel

NDC 70771-1075-1 in bottle of 100 capsules

Budesonide Delayed-Release Capsules 3 mg

100 capsules

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1075-1 in bottle of 100 capsules

Budesonide Delayed-Release Capsules 3 mg

100 capsules

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)